SUO 2017 Kidney Cancer

Viewing 1-20 of 35 articles

SUO 2017: Identifying The Rate And Risks Of Chronic Kidney Disease Development After Cytoreductive Nephrectomy

SUO 2017: Hospital Volume and Short-Term Outcomes after Cytoreductive Nephrectomy

SUO 2017: Cytoreductive Nephrectomy In Patients With Metastatic Renal Cell Carcinoma And Tumor Thrombus – Trends And Effect On Overall Survival

SUO 2017: Perioperative Outcomes of Aspirin Use in Partial Nephrectomy

SUO 2017: Renal Medullary Carcinoma and Collecting Duct Carcinoma of the Kidney

SUO 2017: Validation of The Preoperative Nomogram Predicting 12-Year Probability of Metastatic Renal Cancer

SUO 2017: Keynote-564: Phase 3, Double-blind, Placebo-controlled Trial Of Pembrolizumab As Adjuvant Treatment For Renal Cell Carcinoma

SUO 2017: Sarcomatoid Differentiation in Renal Cell Carcinoma: Does Stage Make A Meaningful Difference On Survival?

SUO 2017: Should Partial Nephrectomy Be Considered Elective In Stage 2 Chronic Kidney Disease? Propensity Score Matched Analysis Of Functional And Survival Outcomes After Radical And Partial Nephrectomy

SUO 2017: Multiplex Partial Nephrectomy In A Solitary Kidney: The NCI Experience With Partial Nephrectomy For Three or More Tumors in Comparison To Standard Partial Nephrectomy In A Solitary Kidney

SUO 2017: Determinants Of Active Surveillance In Patients With Small Renal Masses

SUO 2017: Small Renal Masses and New Guidelines in Management

SUO 2017: Ablative Technologies for Kidney Masses

SUO 2017: Safe And Effective Partial Nephrectomy Is Feasible In Appropriately Selected Patients With Complex (Renal Nephrometry Score 10-12) Renal Tumors: A Multi-institutional Analysis

SUO 2017: Point - Counterpoint: IVC Thrombectomy for Level 2 Tumor Thrombus Versus a Robotic Approach

SUO 2017: The Evolving Management of Advanced Renal Cell Carcinoma

SUO 2017: Point - Counterpoint: IVC Thrombectomy for Level 2 Tumor Thrombus Versus an Open Approach

SUO 2017: Point - Counterpoint: IVC Thrombectomy for Level 2 Tumor Thrombus Versus an Open Approach

SUO 2017: Management of Recurrent Disease in the Current Era of Kidney Cancer Management

SUO 2017: Results on Active Surveillance for Von Hippel-Lindau-Related Renal Tumors Using Size-Based Risk Stratification

1
2